NRC HEALTH - Common Stock, $.001 par value (NRC)

CUSIP: 637372202

Q2 2022 13F Holders as of 30 Jun 2022

Holder snapshot 6 signals
Share change
+28,156
SEC-reported price per share
$38.28
Indexed holders
108
Value change
+$947,742
Number of buys
48
Number of sells
47
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
21,224,610

Security key

637372202

Report period

Q2 2022

Indexed institutions

108

Top holders

10

Ownership snapshot

Top reported holders of NRC - NRC HEALTH - Common Stock, $.001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
KAYNE ANDERSON RUDNICK IN...
Disclosed value leader
KAYNE ANDERSON RUDNICK IN...
Comparable rows
0/15
Latest evidence
31 Mar 2022
13F Highest disclosed value: $130,867,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC has the largest disclosed position value at $130.87M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC's linked filing trail.
Disclosed position value Top 5
KAYNE ANDERSON RUDNICK INVESTMENT... $130.87M
BlackRock Finance, Inc. $36.54M
VANGUARD GROUP INC $33.58M
ATLANTA CAPITAL MANAGEMENT CO L L C $32.45M
Conestoga Capital Advisors, LLC $28.88M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC
13F
Company
13F
—
denominator unverified
$130,867,000
3,300,539 shares
— 31 Mar 2022
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$36,541,000
921,600 shares
— 31 Mar 2022
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$33,585,000
847,034 shares
— 31 Mar 2022
ATLANTA CAPITAL MANAGEMENT CO L L C
13F
Company
13F
—
denominator unverified
$32,452,000
818,452 shares
— 31 Mar 2022
Conestoga Capital Advisors, LLC
13F
Company
13F
—
denominator unverified
$28,877,000
728,297 shares
— 31 Mar 2022
DIMENSIONAL FUND ADVISORS LP
13F
Company
13F
—
denominator unverified
$24,853,000
626,834 shares
— 31 Mar 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
108
Shares
11,521,526
Indexed holders
108
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 indexed holders
114
Q2 2022 indexed holders
108
Indexed holder difference
-6
Investor Q1 2022 Shares Q2 2022 Shares Share Diff Share Chg % Q1 2022 value Q2 2022 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .